Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actikerall in actinic keratosis
NCT02289768Phase 3Completed
- Sponsor
- Almirall
- Start
- Oct 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in actinic keratosis (AK) comparing Actikerall with Vehicle (2 arms). Primary endpoint: Percentage of patients with complete clinical clearance of actinic keratosis lesions in the treatment field at Week 20. Started Oct 2014; status: completed.
02
Drugs
Actikerall
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02289768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02289768.